Clinical Trials
9 trialsNCT03745326 2026-05-19
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated
NCT05191940 2026-03-20
LAPC
EBG MedAustron GmbH
Phase NA Recruiting
NCT06151223 2026-03-10
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
Mayo Clinic
Recruiting
NCT06849063 2026-02-17
Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE
Shengjing Hospital
Recruiting
NCT06526442 2026-02-13
MREDPCM
Shengjing Hospital
Recruiting
NCT05975593 2025-11-12
METEOR-CRATR
Washington University School of Medicine
Phase NA Recruiting
NCT05298722 2025-04-02
PeRFormanCe
University Hospital, Ghent
Phase NA Recruiting
NCT04883450 2024-01-16
PRO-TECT
Kaiser Permanente
Unknown
NCT02683824 2023-09-21
Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers
Stanford University
Phase EARLY_PHASE1 Completed